File Download
Links for fulltext
(May Require Subscription)
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Arsenic trioxide suppresses tumour growth in squamous cell lung carcinoma
| Title | Arsenic trioxide suppresses tumour growth in squamous cell lung carcinoma |
|---|---|
| Authors | |
| Keywords | Medical sciences |
| Issue Date | 2015 |
| Publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk |
| Citation | The 20th Medical Research Conference (MRC 2015), Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 36, abstract no. 53 How to Cite? |
| Abstract | INTRODUCTION: Squamous cell lung carcinoma (SCC) belongs to the second most common subtype in non–small-cell lung carcinoma. Recently, doublet chemotherapy regimens remain the cornerstone of first-line systemic treatment. Therefore, new therapeutic approach is urgently needed. Arsenic trioxide (ATO) is a traditional Chinese medicine which has multiple anti-cancer mechanisms including apoptosis. ATO has been used clinically in acute promyelocytic leukaemia. ATO has been shown to induce apoptosis in lung adenocarcinoma … |
| Description | This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong |
| Persistent Identifier | http://hdl.handle.net/10722/208747 |
| ISSN | 2021 Impact Factor: 1.256 2020 SCImago Journal Rankings: 0.357 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Leung, LL | - |
| dc.contributor.author | Lam, SK | - |
| dc.contributor.author | Ho, JCM | - |
| dc.date.accessioned | 2015-03-18T09:09:18Z | - |
| dc.date.available | 2015-03-18T09:09:18Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | The 20th Medical Research Conference (MRC 2015), Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 36, abstract no. 53 | - |
| dc.identifier.issn | 1024-2708 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/208747 | - |
| dc.description | This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong | - |
| dc.description.abstract | INTRODUCTION: Squamous cell lung carcinoma (SCC) belongs to the second most common subtype in non–small-cell lung carcinoma. Recently, doublet chemotherapy regimens remain the cornerstone of first-line systemic treatment. Therefore, new therapeutic approach is urgently needed. Arsenic trioxide (ATO) is a traditional Chinese medicine which has multiple anti-cancer mechanisms including apoptosis. ATO has been used clinically in acute promyelocytic leukaemia. ATO has been shown to induce apoptosis in lung adenocarcinoma … | - |
| dc.language | eng | - |
| dc.publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk | - |
| dc.relation.ispartof | Hong Kong Medical Journal | - |
| dc.rights | Hong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press. | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Medical sciences | - |
| dc.title | Arsenic trioxide suppresses tumour growth in squamous cell lung carcinoma | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Lam, SK: sklam77@hku.hk | - |
| dc.identifier.email | Ho, JCM: jhocm@hku.hk | - |
| dc.identifier.authority | Ho, JCM=rp00258 | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.hkuros | 242622 | - |
| dc.identifier.volume | 21 | - |
| dc.identifier.issue | suppl. 1 | - |
| dc.identifier.spage | 36, abstract no. 53 | - |
| dc.identifier.epage | 36, abstract no. 53 | - |
| dc.publisher.place | Hong Kong | - |
| dc.identifier.issnl | 1024-2708 | - |